Symetis ACURATE Neo™ Valve Implantation SAVI TF Registry

NCT02306226 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2018-03-19

No results posted yet for this study

Summary

Post-market registry aimed at further evaluating the safety and performance of the ACURATE neo™ Aortic Bioprosthesis and ACURATE TF™ Transfemoral Delivery System in patients with severe aortic stenosis treated with the commercialized device

Conditions

  • Aortic Stenosis

Sponsors & Collaborators

  • Symetis SA

    lead INDUSTRY

Principal Investigators

  • Helge Möllmann, Prof. · Kerckhoff Klinik

Eligibility

Min Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2016-05-31
Completion
2017-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02306226 on ClinicalTrials.gov